The Dubai Biotechnology and ResearchPark (DuBiotech), a major life sciences free zone in the Middle East and a member of TECOM Investments, is participating at the third annual PABME Exhibition and Conference. The event takes place at the Dubai International Convention and Exhibition Centre, UAE, and will continue for its final day tomorrow, Tuesday 25 May, 2010. Launched in 2005, DuBiotech has the mission to create the biggest life sciences cluster in the Middle East. Its business model is based on providing the best environment for major players in the life sciences industry and research through adopting a sustainable strategy and leveraging the benefits of its location in Dubai, while offering free zone benefits and creating a world class infrastructure.
"Dubai is an extremely attractive location for those Pharma companies that want to establish their headquarters to better grow their commercial operations in the Middle East markets, North Africa and other regions well served by the powerful logistic infrastructures available here," said Dr Marco Baccanti, Executive Director, DuBiotech.
"The establishment of a sales and marketing hub in Dubai is the first and most common action taken by many pharma companies since the start of DuBiotech free zone, but more recently we are experiencing an interesting evolution. Some companies are planning to increase their commitment and their investments: they are going to establish in Dubai more knowledge and labour intensive operations, such as research projects (clinical trials), logistics operations, even manufacturing and packaging plants."
PABME 2010 will offer pharmaceutical and biotechnology scientists and practitioners from around the Middle East and the world the opportunity to interact, network and exchange ideas and bring themselves and their organisation to the forefront of the discipline.
